Literature DB >> 2839505

DNA-dependent ATPase activity associated with vaccinia virus early transcription factor.

S S Broyles1, B Moss.   

Abstract

Vaccinia virus early transcription factor (VETF) is required for efficient expression of the early class of viral genes in vitro. The factor copurified with an ATPase activity that was stimulated by DNA. In this report we show that the ATPase remains associated with the factor upon glycerol gradient sedimentation. Under these conditions VETF sedimented at a rate of 7.6 S suggesting that it may be a heterodimer of the Mr 82,000 and 77,000 polypeptides. Of the common nucleoside triphosphates, only ATP and dATP were hydrolyzed by the VETF-associated ATPase. The ATP analog gamma-thio ATP was not a substrate. The VETF-associated ATPase activity was stimulated up to 30-fold by the presence of polynucleotides. DNA was a much more effective cofactor for the ATPase than was RNA, and duplex polydeoxyribonucleotides were preferred. The enzymatic and physical properties of the VETF-associated ATPase distinguished it from all three vaccinia ATPase activities previously described, nucleoside triphosphate phosphohydrolases I and II, and capping enzyme. Except for the preference for double-stranded DNA, the substrate and cofactor requirements of the VETF-associated ATPase most closely resembled those of nucleoside triphosphate phosphohydrolase I. However, VETF-ATPase was not inhibited by polyclonal antibody to the latter enzyme. The association of an ATPase with an early gene transcription factor may explain the previously described requirement for ATP hydrolysis in transcription.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2839505

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Ternary complex formation by vaccinia virus RNA polymerase at an early viral promoter: analysis by native gel electrophoresis.

Authors:  J Hagler; S Shuman
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

2.  Genetic evidence for involvement of vaccinia virus DNA-dependent ATPase I in intermediate and late gene expression.

Authors:  M S Künzi; P Traktman
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

3.  Early transcription factor subunits are encoded by vaccinia virus late genes.

Authors:  P D Gershon; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

4.  cis- and trans-acting elements involved in reactivation of vaccinia virus early transcription.

Authors:  K Masternak; R Wittek
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

5.  DNA sequences that regulate expression of a vaccinia virus late gene (L65) and interact with a DNA-binding protein from infected cells.

Authors:  J N Miner; D E Hruby
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

6.  Identification of factors specific for transcription of the late class of vaccinia virus genes.

Authors:  C F Wright; B Moss
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

7.  Transcription of a poxvirus early gene is regulated both by a short promoter element and by a transcriptional termination signal controlling transcriptional interference.

Authors:  B S Ink; D J Pickup
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

8.  Vaccinia virus RNA helicase: an essential enzyme related to the DE-H family of RNA-dependent NTPases.

Authors:  S Shuman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

9.  Vaccinia virus nucleoside triphosphate phosphohydrolase I controls early and late gene expression by regulating the rate of transcription.

Authors:  M Diaz-Guerra; M Esteban
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

10.  Three adjacent genes of African swine fever virus with similarity to essential poxvirus genes.

Authors:  P C Roberts; Z Lu; G F Kutish; D L Rock
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.